These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6671456)

  • 1. Treatment of idiopathic pituitary dwarfism with methionyl human growth hormone.
    Takano K; Shizume K; Hizuka N; Hibi I; Kato K; Kohno H; Kondo T; Ogawa M; Okada Y; Sudo M
    Endocrinol Jpn; 1983 Aug; 30(4):523-7. PubMed ID: 6671456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of pituitary dwarfism with methionyl human growth hormone in Japan.
    Takano K; Shizume K; Hizuka N; Okuno A; Umino T; Kobayashi Y; Kusano S; Nakajima H; Irie M; Hibi I
    Endocrinol Jpn; 1986 Oct; 33(5):589-96. PubMed ID: 3830068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical experience with somatrem in Japan.
    Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():19-24. PubMed ID: 3296635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of pituitary dwarfism with authentic recombinant human growth hormone (SM-9500).
    Takano K; Shizume K; Hibi I; Okuno A; Hanyu K; Suwa S; Nakajima H; Kondo T; Kato K; Iwatani N
    Endocrinol Jpn; 1987 Apr; 34(2):291-7. PubMed ID: 3622395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case report of growth attenuation during methionyl human growth hormone treatment.
    Okada Y; Taira K; Takano K; Hizuka N
    Endocrinol Jpn; 1987 Aug; 34(4):621-6. PubMed ID: 3678156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Turner's syndrome with methionyl human growth hormone for six months.
    Takano K; Hizuka N; Shizume K
    Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of second somatonorm treatment in idiopathic growth hormone deficiency dwarfism].
    Bao X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Dec; 13(6):443-6. PubMed ID: 1838961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children.
    Kaplan SL; Underwood LE; August GP; Bell JJ; Blethen SL; Blizzard RM; Brown DR; Foley TP; Hintz RL; Hopwood NJ
    Lancet; 1986 Mar; 1(8483):697-700. PubMed ID: 2870221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pituitary dwarfism with biosynthetic growth hormone.
    Bierich JR
    Acta Paediatr Scand Suppl; 1986; 325():13-8. PubMed ID: 3296634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current clinical trials with authentic recombinant human growth hormone in Japan.
    Takano K; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():93-7. PubMed ID: 3296643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial with authentic recombinant somatropin in Japan.
    Takano K; Shizume K; Hibi I; Okuno A; Nakajima H; Suwa S; Nogawa T; Kondo T; Momoi T; Iwatani N
    Acta Paediatr Scand Suppl; 1987; 331():18-24. PubMed ID: 3300151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of pituitary dwarfism with recombinant human growth hormone. A multicenter study].
    Bierich JR; Ranke MB; Beyer P; Bittner P; Borkenstein H; Brämswig J; Butenandt O; Kollmann F; Stöver B; Schweikert HU
    Dtsch Med Wochenschr; 1986 Mar; 111(13):483-9. PubMed ID: 3514193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A screening test to detect HGH-antibodies in pituitary dwarfs treated with HGH preparation by the radio-immunoassay with double antibody technique.
    Okada Y; Takahashi T; Kumahara Y
    Endocrinol Jpn; 1977 Dec; 24(6):589-93. PubMed ID: 606547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of anti-hGH antibody analysis].
    Takano K
    Nihon Rinsho; 1990 Feb; 48 Suppl():861-3. PubMed ID: 2355625
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolated human growth hormone deficiency due to the hGH-I gene deletion with (type IA) and without (the Israeli-type) hGH antibody formation during hGH therapy.
    Nishi Y; Masuda H; Nishimura S; Kihara M; Suwa S; Tachibana K; Takeda M; Okada Y; Matsuda I
    Acta Endocrinol (Copenh); 1990 Feb; 122(2):267-71. PubMed ID: 1969217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical experience with the treatment of dwarfism caused by growth hormone deficiency using biosynthetic somatotropin (Somatonorm)].
    Dorantes-Alvarez L; Parra-Paredes MS
    Bol Med Hosp Infant Mex; 1989 Aug; 46(8):531-6. PubMed ID: 2803536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of somatomedin A and growth during long-term treatment of patients with pituitary dwarfism with human growth hormone.
    Takano K; Hizuka N; Shizume K; Hasumi Y
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):385-97. PubMed ID: 229685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy in dwarfism. Use of genetically produced growth hormone in practice].
    Neugebauer M
    Med Monatsschr Pharm; 1986 Nov; 9(11):345-6. PubMed ID: 3543630
    [No Abstract]   [Full Text] [Related]  

  • 19. Recombinant DNA produced somatropin in the treatment of prepubertal growth hormone deficient children.
    Chang TC; Kuo HF; Liu PC; Shih KC; Zeisel HJ; Ho LT
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jan; 47(1):7-12. PubMed ID: 1848467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone treatment in Turner's syndrome.
    Takano K; Hizuka N; Shizume K
    Acta Paediatr Scand Suppl; 1986; 325():58-63. PubMed ID: 3473892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.